Characterization of Arrhythmia-induced Cardiomyopathy

Status Recruiting

Clinical Trial Summary

The goal of the this observational study is to gather clinically available data on patients presenting with a suspicion for arrhythmia-induced cardiomyopathy (AiCM) at the University Hospital Basel.

Clinical Trial Description

Current studies indicate that AiCM is an under-recognized and an underestimated clinical entity and its prevalence is poorly documented. This project consists of a retrospective longitudinal cohort and case-control study followed by a prospective observational cohort study. The retrospective pilot study (1200 patients) is to define the incidence of AiCM in patients who presented to the University Hospital of Basel with a reduced left ventricular ejection fraction before or after the diagnosis of an arrhythmia suggestive to lead to an AiCM. The prospective study part (1500 patients) is to evaluate the predictors of adverse events and re-hospitalizations in patients with a suspicion of AiCM. The diagnosis of AiCM will be established using a "goldstandard diagnosis": 2 independent cardiologists will adjudicate the diagnosis based on all data from the initial hospital stay and follow-up including ECG, laboratory measurements, vital signs, echocardiography, coronary angiography, stress testing and other cardiovascular diagnostic steps. The most likely diagnosis will be chosen among a list of comprehensive, pre-selected choices. In cases of disagreement of the two reviewers, diagnosis will be discussed with a third senior physician and decision made. In order to optimize the care of patients with AiCM, the researchers intend to determine the prevalence of AICM, evaluate diagnostic criteria that allow an early diagnosis of AICM, and evaluate the current therapeutic management and prognosis of patients with AICM. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05662293
Study type	Observational
Source	University Hospital, Basel, Switzerland
Contact	Patrick Badertscher, MD
Phone	+41 61 556 58 23
Email	patrick.badertscher@usb.ch
Status	Recruiting
Phase
Start date	June 10, 2021
Completion date	January 2027

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05371496` - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction	Phase 2
Completed	`NCT02892448` - Cardiac MRI for Metal on Metal Hip Resurfacing	N/A
Active, not recruiting	`NCT02537782` - Myocardial Work and Metabolism in CRT	N/A
Completed	`NCT02525185` - Contractile Reserve in Dyssynchrony: A Novel Principle to Identify Candidates for Cardiac Resynchronization Therapy
Terminated	`NCT01705509` - The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC)	N/A
Completed	`NCT00999947` - Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy	N/A
Completed	`NCT00626028` - Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Testing	Phase 3
Recruiting	`NCT00138931` - Genetics of Cardiovascular and Neuromuscular Disease
Withdrawn	`NCT02838355` - Employing End Tidal Capnography in Continuous Flow Ventricular Assist Device Patients	N/A
Completed	`NCT01085955` - Investigation in Pregnancy Associate Cardiomyopathy	N/A
Withdrawn	`NCT00428103` - Effects of Mitral Valve Repair With the Geoform Ring on Cardiomyopathy	N/A
Recruiting	`NCT00273637` - Registry and Survey of Women With Pregnancy Related Cardiomyopathy	N/A
Completed	`NCT00810550` - Carotid Ultrasound in the Evaluation of Heart Failure	N/A
Completed	`NCT04603521` - Patients' Long-Term Survival of Obstructive Hypertrophic Cardiomyopathy (HCM)
Enrolling by invitation	`NCT03057561` - Efficacy of Dotarem® (Gd-DOTA) Versus Gadovist® (Gd-DO3A-butrol) for Late Gadolinium Enhancement Cardiac Magnetic Resonance	N/A
Completed	`NCT00027170` - Technical Development of Cardiovascular Magnetic Resonance Imaging
Not yet recruiting	`NCT02917395` - Evaluate the Efficacy of Disopyramide Therapy in Hypertrophic Obstructive Cardiomyopathy Patients	N/A
Completed	`NCT02164721` - Multicenter Automatic Defibrillator Implantation Trial - Chemotherapy-Induced Cardiomyopathy	N/A
Completed	`NCT02331264` - Cardiac Assessment of Patients With Hip Implants	N/A
Completed	`NCT02270840` - Budapest Upgrade CRT Study (Version 009-4.1)	N/A